These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4530511)

  • 21. [The dynamic calcitonin and parathyroid hormone levels of the blood in patients with acute and chronic odontogenic osteomyelitis of the mandible].
    Seidbekov OS
    Stomatologiia (Mosk); 1993; 72(3):30-2. PubMed ID: 8236295
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hemosorption in the combined therapy of suppurative-septic processes of the maxillofacial area].
    Zakharov IuS; Bolgov DF
    Stomatologiia (Mosk); 1985; 64(3):45-7. PubMed ID: 3863281
    [No Abstract]   [Full Text] [Related]  

  • 23. [Experience with the treatment of children with suppurative inflammatory processes in the maxillofacial region].
    Chmyrev VS
    Stomatologiia (Mosk); 1974; 53(4):49-51. PubMed ID: 4529134
    [No Abstract]   [Full Text] [Related]  

  • 24. [Prognosis of the severity of odontogenic osteomyelitis on the basis of plasma concentrations of potassium and sodium ions].
    Artiushenko NK; Vaĭnilovich IN
    Vestn Khir Im I I Grek; 1983 Feb; 130(2):59-62. PubMed ID: 6845584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Means of decreasing complications in patients with severe inflammatory diseases of the maxillofacial area].
    Zakharova GN; Bulkin VA
    Stomatologiia (Mosk); 1987; 66(3):37-9. PubMed ID: 3475830
    [No Abstract]   [Full Text] [Related]  

  • 26. [Use of hyperbaric oxygenation in the combined treatment of acute inflammatory processes of the soft tissues of the maxillofacial area].
    Kurakin AV; Karapetian IS; Volozhin AI; Sidel'nikova GM; Pomerantseva EN
    Stomatologiia (Mosk); 1982; 61(5):36-8. PubMed ID: 6959389
    [No Abstract]   [Full Text] [Related]  

  • 27. [The status and outlook in the prevention and treatment of suppurative inflammatory diseases of the maxillofacial area].
    Bazhanov NN; Kozlov VA; Robustova TG; Maksimovskiĭ IuM
    Stomatologiia (Mosk); 1997; 76(2):15-9. PubMed ID: 9163076
    [No Abstract]   [Full Text] [Related]  

  • 28. [Differences in the immune status of patients with chronic odontogenic inflammatory processes of the maxillofacial area].
    Robustova TG; Kostishin ID
    Stomatologiia (Mosk); 1986; 65(4):31-3. PubMed ID: 3462977
    [No Abstract]   [Full Text] [Related]  

  • 29. [Combined treatment of suppurative inflammatory diseases of the maxillofacial area using thymalin].
    Shimchenko PIa; Morozov VG; Khavinson VKh; Orlov VS
    Vestn Khir Im I I Grek; 1981 Oct; 127(10):94-7. PubMed ID: 6895567
    [No Abstract]   [Full Text] [Related]  

  • 30. [Use of a chloracetophos ointment in the combined treatment of acute odontogenic inflammatory processes of the maxillofacial area].
    Khamitov FS; Faizov TT; Berim MG
    Stomatologiia (Mosk); 1985; 64(1):35-7. PubMed ID: 3857735
    [No Abstract]   [Full Text] [Related]  

  • 31. [Experience in treating children with odontogenic osteomyelitis of the jaws].
    Supiev TK
    Stomatologiia (Mosk); 1987; 66(4):61-4. PubMed ID: 3478874
    [No Abstract]   [Full Text] [Related]  

  • 32. [The characteristics of treating odontogenic osteomyelitis against a background of malaria in the population of the Republic of Burundi].
    Saĭ VG
    Stomatologiia (Mosk); 1992; (1):62-3. PubMed ID: 1440684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Specific immunotherapy in the overall treatment of odontogenic inflammatory diseases].
    Biberman IaM
    Stomatologiia (Mosk); 1976; 55(4):30-3. PubMed ID: 1071504
    [No Abstract]   [Full Text] [Related]  

  • 34. [Immunity of patients with suppurative-inflammatory processes of the maxillofacial area].
    Zavada IG; Zuev VP; Makhlin NV; Sheĭnberg VM; Tikhonova GB
    Stomatologiia (Mosk); 1984; 63(4):82-5. PubMed ID: 6382691
    [No Abstract]   [Full Text] [Related]  

  • 35. [Serum immunoglobulin content of patients with inflammatory diseases of the maxillofacial area].
    Shcherbatiuk DI; Anestiiadi MIa
    Stomatologiia (Mosk); 1984; 63(5):37-9. PubMed ID: 6437017
    [No Abstract]   [Full Text] [Related]  

  • 36. [Odontogenic anaerobic gas gangrene of the maxillofacial area].
    Ruzin GP; Grishchuk IA; Andrusiak IM; Kishchuk PD
    Stomatologiia (Mosk); 1991; 70(3):36-7. PubMed ID: 1926204
    [No Abstract]   [Full Text] [Related]  

  • 37. [Ways to prevent and treat disseminated inflammatory diseases of the maxillofacial area and their complications].
    Robustova TG; Gubin MA; Tsarev VN; Lebedev KA; Ushakov RV; Starodubtsev VS; Fomichev EV
    Stomatologiia (Mosk); 1995; 74(1):31-3. PubMed ID: 7770875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Nonspecific body resistance in the acetylator phenotype of patients with odontogenic inflammatory processes in the maxillofacial area].
    Azimov M; Krakovskiĭ ME; Ashirmetov AKh
    Stomatologiia (Mosk); 1990; 69(6):33-5. PubMed ID: 2087715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The use of physiotherapeutic factors in the combined treatment of patients with diseases of the maxillofacial area].
    Ivasenko PI; Popov AK; Ponomarenko ID
    Stomatologiia (Mosk); 1996; Spec No():59-60. PubMed ID: 9281151
    [No Abstract]   [Full Text] [Related]  

  • 40. [The prediction of the outcomes of severe odontogenic inflammatory diseases of the maxillofacial area taking into account biorhythms].
    Taĭchenachev AIa
    Stomatologiia (Mosk); 1998; 77(6):15-8. PubMed ID: 10067408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.